These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Methylphenidate: pharmacology, indication and potential of abuse]. Tagaya H Nihon Rinsho; 2010 Aug; 68(8):1550-5. PubMed ID: 20715493 [TBL] [Abstract][Full Text] [Related]
3. [Methylphenidate misuse]. Bruggisser M; Bodmer M; Liechti ME Praxis (Bern 1994); 2012 Feb; 101(5):299-305. PubMed ID: 22377977 [TBL] [Abstract][Full Text] [Related]
4. A controlled trial of methylphenidate in adults with attention deficit/hyperactivity disorder and substance use disorders. Carpentier PJ; de Jong CA; Dijkstra BA; Verbrugge CA; Krabbe PF Addiction; 2005 Dec; 100(12):1868-74. PubMed ID: 16367988 [TBL] [Abstract][Full Text] [Related]
6. Misuse of Methylphenidate. Clemow DB Curr Top Behav Neurosci; 2017; 34():99-124. PubMed ID: 26695166 [TBL] [Abstract][Full Text] [Related]
7. Megadose intranasal methylphenidate (ritalin) abuse in adult attention deficit hyperactivity disorder. Coetzee M; Kaminer Y; Morales A Subst Abus; 2002 Sep; 23(3):165-9. PubMed ID: 12444349 [TBL] [Abstract][Full Text] [Related]
8. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)]. Golubchik P; Sever J; Weizman A Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124 [TBL] [Abstract][Full Text] [Related]
9. Attention-deficit-hyperactivity disorder: an update. Dopheide JA; Pliszka SR Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419 [TBL] [Abstract][Full Text] [Related]
10. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Leonard BE; McCartan D; White J; King DJ Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851 [No Abstract] [Full Text] [Related]
12. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. Kollins SH J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325 [TBL] [Abstract][Full Text] [Related]
13. ADHD, substance use disorders, and psychostimulant treatment: current literature and treatment guidelines. Kollins SH J Atten Disord; 2008 Sep; 12(2):115-25. PubMed ID: 18192623 [TBL] [Abstract][Full Text] [Related]
14. [The medical treatment of attention deficit hyperactivity disorder (ADHD) with amphetamines in children and adolescents]. Frölich J; Banaschewski T; Spanagel R; Döpfner M; Lehmkuhl G Z Kinder Jugendpsychiatr Psychother; 2012 Sep; 40(5):287-99; quiz 299-300. PubMed ID: 22869222 [TBL] [Abstract][Full Text] [Related]
15. The potential for misuse and abuse of medications in ADHD: a review. Clemow DB; Walker DJ Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651 [TBL] [Abstract][Full Text] [Related]
16. Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD). Retz W; Retz-Junginger P Eur Arch Psychiatry Clin Neurosci; 2014 Nov; 264 Suppl 1():S35-43. PubMed ID: 25231833 [TBL] [Abstract][Full Text] [Related]
17. Prescribing methylphenidate for moderate ADHD. McClure I BMJ; 2013 Oct; 347():f6216. PubMed ID: 24133145 [No Abstract] [Full Text] [Related]
18. Adults with attention deficit hyperactivity disorder: assessment and treatment considerations. Murphy K Semin Speech Lang; 1996 Aug; 17(3):245-53; quiz 254. PubMed ID: 8912439 [TBL] [Abstract][Full Text] [Related]
19. Intranasal abuse of prescribed methylphenidate. Garland EJ J Am Acad Child Adolesc Psychiatry; 1998 Jun; 37(6):573-4. PubMed ID: 9628076 [No Abstract] [Full Text] [Related]
20. Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature. Kraemer M; Uekermann J; Wiltfang J; Kis B Clin Neuropharmacol; 2010 Jul; 33(4):204-6. PubMed ID: 20571380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]